Colombo N, Gadducci A, Sehouli J, Rulli E, et al. INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 m Br J Cancer 2023 Feb 9. doi: 10.1038/s41416-022-02108.
PMID: 36759720